This Solicitation opportunity from Government of Canada was posted on September 27, 2022. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Doxycycline Hyclate Tablets or Capsules, 100 mg
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Department of National Defence is seeking a contractor to supply Doxycycline Hyclate tablets or capsules of 100 mg for the treatment of Canadian Armed Forces members exposed to bacterial biological warfare agents. The contract remains active from the start date through March 31, 2026. The initial requirement mandates the delivery of 259,200 units by March 31, 2023. Additionally, the contract includes three optional requirements, each allowing for the procurement of up to 259,200 units with respective deadlines of March 31 for the years 2024, 2025, and 2026.
General Info
Place of Performance
*Ontario (except NCR), CANSet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
